1. |
Wu TX, Liu GJ, Zhang MM, et al. Systematic review of benefits and harms of artemisinin-type compounds fro preventing schistosomiasis. Natl Med J China, 2003, 83(14): 1219-1224.
|
2. |
Andreas L, David L, Sackett RS, et al. An assessment of clinically useful measures of the consequences of treatment. The New Eng J Med, 1988, 318(26): 1728-1733.
|
3. |
Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology. The Essentials. 3rd edition. Williams & Wilkins A Waverly Company. Baltimore, Maryland, USA.
|
4. |
Gordon Guyatt, Drummond Rennie. Users’ Guides to the medical literature. Essentials of Evidence-Based Cl inical Practice. JAMA ARCHIVES JORNALS. AMA Press.
|
5. |
Johansen HK, Gotzsche PC. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. Cochrane Database of Systematic Reviews, Issue 2, 2002, (2): CD000239.
|
6. |
吳泰相, 劉關鍵, 張鳴明, 等. 青蒿素類藥物預防日本血吸蟲感染效果及安全性的系統評價. 中華醫學雜志, 2003, 83(14): 1219-1224.
|